Once thought improbable, in vitro human models are demonstrating technological prowess in a growing range of applications.

"However, a model like this could conceivably be useful for early drug screening, to study how a drug might cross a barrier similar to the blood-brain barrier, in preparation for animal or human ...

In this webinar, Scott Kelsey, Kevin Grady, and Ming-I Huang will highlight how angiogenesis and vascularized in vitro models ...

Animal models are often flawed and offer incomplete representations of human disease. Yet we have long relied on their data to establish the risk/benefit for experimental drugs.

Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results ...

The pilot project is part of Project Mosaic, an effort to create better disease models of sporadic ALS and spur development of precision drugs.

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost without AI.

CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The ...